Genetico
Center of Genetics and Reproductive Medicine GENETICO LLC

Project Information

Investment idea:

to participate in the development of the largest Russian player in the field of medical (including reproductive) genetics.

Current status:

technology transfer has been implemented, a wide sales network has been built, a modern laboratory has been organized, partnerships with leading global brands - Illumina, Roсhe have been established.

Field of activity:

Provision of a complex of medical and genetic services for the purpose of early detection and prevention of hereditary diseases, as well as pathologies with a genetic component, including in the reproductive sphere:

  • Preimplantation genetic screening (PGS)/diagnosis of early-stage embryos during an IVF cycle
  • Non-invasive prenatal testing (NIPT) of fetal chromosome aberrations using maternal venous blood
  • Neonatal screening
  • Screening for couples in pregnancy planning
  • Screening for identification of genetic predisposition to oncological diseases
  • Screening for the selection of better therapy depending on the genetics
  • Reprobank

Market potential in Russia

Key performance indicators and market position

  • The company's share in the market of NIPT and PGS services is 30% and 40%, respectively;
  • The company conducts its own R & D in the field of genetics;
  • The entire test cycle is performed in own laboratories;
  • It has its own genetic counseling and bioinformatics service;
  • Efficiency at all stages (from sampling to issuing the result to the patient).

Financial performance

Revenue dynamics, million rubles:

Would you like to know more?
Your application
To list Up